
The FDA and Novartis have agreed to move forward with a Phase 3 clinical trial to evaluate the effectiveness of …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

